Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.99 USD
5%
Market Closed
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Other Current Assets
|
Adaptive Biotechnologies Corp
Other Current Assets Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Other Current Assets
$9.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Current Assets
$1.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
|
Danaher Corp
NYSE:DHR
|
Other Current Assets
$1.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Other Current Assets
$116.9m
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-1%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Current Assets
$262m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-4%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Current Assets
$687m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
18%
|
See Also
What is Adaptive Biotechnologies Corp's Other Current Assets?
Other Current Assets
9.9m
USD
9.9m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Other Current Assets amounts to 9.9m USD.
What is Adaptive Biotechnologies Corp's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
8%
8%
Over the last year, the Other Current Assets growth was 1%. The average annual Other Current Assets growth rates for Adaptive Biotechnologies Corp have been -10% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
